- Home
- PTGX vs CUBI Comparison
PTGX vs CUBI Comparison
Compare PTGX & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- CUBI
- Stock Information
- Founded
- PTGX 2006
- CUBI 1994
- Country
- PTGX United States
- CUBI United States
- Employees
- PTGX N/A
- CUBI N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- CUBI Major Banks
- Sector
- PTGX Health Care
- CUBI Finance
- Exchange
- PTGX Nasdaq
- CUBI Nasdaq
- Market Cap
- PTGX 2.8B
- CUBI 1.4B
- IPO Year
- PTGX 2016
- CUBI 2012
- Fundamental
- Price
- PTGX $47.91
- CUBI $46.46
- Analyst Decision
- PTGX Strong Buy
- CUBI Buy
- Analyst Count
- PTGX 7
- CUBI 8
- Target Price
- PTGX $52.83
- CUBI $63.86
- AVG Volume (30 Days)
- PTGX 450.1K
- CUBI 290.2K
- Earning Date
- PTGX 11-08-2024
- CUBI 10-31-2024
- Dividend Yield
- PTGX N/A
- CUBI N/A
- EPS Growth
- PTGX N/A
- CUBI 33.08
- EPS
- PTGX 2.75
- CUBI 7.41
- Revenue
- PTGX $319,120,000.00
- CUBI $722,462,000.00
- Revenue This Year
- PTGX $400.33
- CUBI N/A
- Revenue Next Year
- PTGX N/A
- CUBI $11.71
- P/E Ratio
- PTGX $17.54
- CUBI $6.12
- Revenue Growth
- PTGX 125.73
- CUBI 25.87
- 52 Week Low
- PTGX $13.76
- CUBI $38.69
- 52 Week High
- PTGX $48.89
- CUBI $68.49
- Technical
- Relative Strength Index (RSI)
- PTGX 60.40
- CUBI 48.18
- Support Level
- PTGX $45.33
- CUBI $44.31
- Resistance Level
- PTGX $48.89
- CUBI $47.11
- Average True Range (ATR)
- PTGX 1.28
- CUBI 1.57
- MACD
- PTGX 0.11
- CUBI 0.05
- Stochastic Oscillator
- PTGX 77.11
- CUBI 28.96
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources, and Financial Products and Services. The majority of revenue is derived from commercial lending.